Market Development Director​/Thought Leader Liaison *Rare Disease* (Midwest

The Job Details are as follows:

California, US residents .

We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies and technologies that expand the availability of transplantable organs.

United Therapeutics (Nasdaq:
UTHR
) seeks to advance treatments for rare, deadly diseases. Founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (
PAH
), we now have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (
PH-ILD
), and neuroblastoma, a rare pediatric cancer. Our near‑term pipeline seeks additional therapies for PAH and pulmonary fibrosis (
PF
).

We are working to create manufactured organs to address the shortage of kidneys, hearts, lungs and livers available for transplant, believing that an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end‑stage organ diseases for which transplant is not currently an option.

IL, WI, MO, IA, MN, SD, ND (subject to change)

As a Market Development Director/Thought Leader Liaison, you are a strategic relationship builder who thrives at the intersection of science and strategy. You earn trust with Key Opinion Leaders and key health systems, translating market insights into meaningful advocacy and regional impact. You’re confident engaging executive stakeholders, collaborating cross‑functionally on launches and speaker programs, and aligning strategy with action. Mission‑driven and highly accountable, you operate with integrity—motivated by strengthening partnerships and advancing better outcomes for patients.

• Develop and foster ongoing relationships with KOLs and key accounts, building advocacy and belief in disease state and UT brands. Collaborate with other functions to plan and coordinate interactions with KOLs, ensuring a positive customer experience.
• Develop a business plan aligned with achieving goals and objectives and review with RDMD on a quarterly basis.
• Initiate and lead meetings with regional, field‑based functions to identify key issues and trends in the area. Gather feedback and intel in the region to inform KOL mapping, regional strategy, annual brand planning, and other initiatives.
• Collaborate with brand team/internal marketing to assist in launch planning, launches, regional marketing initiatives and other programs. Attend relevant Advisory Boards & market research events, where appropriate, for understanding, development & refinement of strategy and key initiatives. Provide project KOL recommendations and facilitate KOL engagements.
• Liaise between key accounts and UT to provide an on‑the‑ground perspective and to triage requests to the proper team and quarterback appropriate follow‑up. Utilize X‑Fly to capture key insights.
• Understand and maintain current knowledge of the core disease state(s), market, business strategies, plans, and goals and translate them into needs and engagement plans for interactions with KOLs.
• Assist in development and delivery of speaker programs, including developing and training speakers, developing content, attending programs, monitoring surveys, and participating in annual program calibration. Provide ad‑hoc training to speakers who are unable to attend live or virtual training. Work effectively with corporate compliance team to ensure appropriate policy application.
• Operate in compliance with United Therapeutics compliance policies and standard operating procedures, and all applicable federal and state laws and guidance relating to product promotion and information dissemination including, but not limited to, the Federal Food, Drug, and Cosmetic Act, the FDA’s implementing regulations, the Federal Anti‑Kickback Statute, the False Claims Act, PhRMA, Corporate Code of Business Conduct and the Office of the Inspector General’s Compliance Program Guidance for Pharmaceutical Manufacturers.
• Report all expenses, auto mileage, call activity, X‑Fly,…